MARKET

EYPT

EYPT

Eyepoint Pharmac
NASDAQ
6.52
-0.31
-4.54%
After Hours: 6.84 +0.32 +4.91% 19:24 03/14 EDT
OPEN
6.83
PREV CLOSE
6.83
HIGH
7.06
LOW
6.44
VOLUME
983.25K
TURNOVER
--
52 WEEK HIGH
24.37
52 WEEK LOW
5.54
MARKET CAP
448.11M
P/E (TTM)
-2.8048
1D
5D
1M
3M
1Y
5Y
1D
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: OnKure Therapeutics (OKUR) and EyePoint Pharmaceuticals (EYPT)
TipRanks · 4d ago
Weekly Report: what happened at EYPT last week (0303-0307)?
Weekly Report · 5d ago
JonesTrading Remains a Buy on EyePoint Pharmaceuticals (EYPT)
TipRanks · 03/07 21:36
EyePoint Pharma’s Earnings Call: Clinical Progress Amid Financial Challenges
TipRanks · 03/07 00:10
EyePoint Pharmaceuticals Price Target Maintained With a $33.00/Share by Chardan Capital
Dow Jones · 03/06 22:07
EyePoint Pharmaceuticals Is Maintained at Buy by Chardan Capital
Dow Jones · 03/06 22:07
Demystifying EyePoint Pharmaceuticals: Insights From 4 Analyst Reviews
Benzinga · 03/06 22:01
More
About EYPT
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the business of developing and commercializing ophthalmic products for the treatment of eye diseases. The Company's pipeline leverages its Durasert technology (Durasert) for sustained intraocular drug delivery, including delivery of EYP-1901, is an investigational sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated retinal diseases. Its additional pipeline programs include EYP-2301, a promising TIE-2 agonist, razuprotafib, formulated in Durasert E to potentially improve outcomes in serious retinal diseases. EYP-1901 is presently in Phase 2 clinical trials as a sustained delivery treatment for wet age-related macular degeneration (wet AMD), no proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The Company’s other products include YUTIQ, and DEXYCU.

Webull offers Eyepoint Pharmaceuticals Inc stock information, including NASDAQ: EYPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EYPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EYPT stock methods without spending real money on the virtual paper trading platform.